Cornea Treatment Articles & Analysis
3 news found
Glaukos’iLinkpharmaceutical platform consists of novel single-use drug formulations that are bio-activated by proprietary systems through the delivery of ultraviolet light to the cornea to induce a reaction called corneal cross-linking designed to strengthen, stabilize and reshape the cornea. ...
EyeYon Medical, founded by two leading cornea specialists – Ofer Daphna and Arie Markovich – and medical device entrepreneur Nahum Ferera, decided to address the shortage by developing EndoArt®. The ready-to-use, universally-available endothelial graft essentially replaces endothelial keratoplasty (DSAEK and DMEK) as the first line of treatment ...
Vision accessibility for anyone, anywhere Ready for use, Artificial Endothelial Layer EndoArt® aims to eliminate the need for donor tissue in corneal edema treatment. All you wanted to know about the disruptive EndoArt® Artificial Endothelial Layer at one publication! Take a look at this exciting article with the latest, most updated results of our First in Human trial, already ...